News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
70 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17555)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (92)
2 (55)
3 (1)
4 (4)
5 (65)
6 (116)
7 (86)
8 (101)
9 (46)
10 (4)
11 (5)
12 (90)
13 (97)
14 (81)
15 (116)
16 (43)
17 (1)
18 (12)
19 (98)
20 (90)
21 (83)
22 (111)
23 (47)
26 (66)
27 (70)
28 (93)
29 (55)
30 (39)
31 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
26
27
28
29
30
31
Biotech Beach
Imprimis Pharmaceuticals Issued Composition Patent for Non-Opioid Conscious Sedation Formulation
Non-opioid IV-free procedural sedation and pain relief could aid in the battle against opioid abuse.
March 27, 2018
·
5 min read
Drug Development
Erasmus MC Completes First Step in the Evolution of Online Adaptive Radiation Therapy with the CyberKnife® System
New Clinical Trial Evaluates Use of Online-Adaptive Stereotactic Body Radiation Therapy Approach in the Treatment of Oligometastases
March 27, 2018
·
5 min read
Business
Motus GI Expands Intellectual Property Portfolio with New U.S. Patent Issuance for the Pure-Vu® System
Expansion of IP portfolio further supports Company’s strategic pathway for flagship product to become standard of care.
March 27, 2018
·
4 min read
FDA
Convexity Scientific Receives FDA Clearance For Its FLYP™ Nebulizer, Unveils The New Device At Medtrade Spring
Lightweight, pocket-portable nebulizer poised to lead the next generation in respiratory disease care and treatment.
March 27, 2018
·
2 min read
Business
$200,000 in donations from cryptocurrency supports Charcot-Marie-Tooth Disease Research
True Reply and the Hereditary Neuropathy Foundation (HNF) have collaborated to enhance patient focused research and to improve clinical trial design, clinical trial patient recruitment and to enhance the knowledge of what matters most to patients that are living with Charcot-Marie-Tooth Disease.
March 27, 2018
·
3 min read
Pharm Country
New survey reveals many misconceptions exist about allergies, illustrating the need for greater education
Sanofi teams up with television personality Adam Savage and allergist Dr. Neeta Ogden to help dispel common allergy misconceptions with facts
March 27, 2018
·
5 min read
FDA
U.S. Food and Drug Administration (FDA) Accepts Bristol-Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for Previously Treated Patients with MSI-H or dMMR Metastatic Colorectal Cancer for Priority Review
The FDA also granted the Opdivo plus Yervoy combination Breakthrough Therapy Designation for this potential indication.
March 27, 2018
·
28 min read
Newron Pharmaceuticals Announces Shareholders Accepted All Motions at the AGM 2018
About 24.9% of Newron’s total capital of 17,844,345 shares were represented at the meeting.
March 27, 2018
·
1 min read
FDA
FDA Approves New Innovations on Hologic’s 3Dimensions™ Mammography System, the Fastest, Highest Resolution Breast Tomosynthesis System Ever(1)
Latest Breast Cancer Screening Improvements Launched as Company Marks Installation of More Than 5,000 3D Mammography™ Systems Throughout the United States
March 27, 2018
·
6 min read
Business
Inflammation Testing Prompts Care Changes Leading to Significantly Lower Levels in Patients with Increased Cardiovascular Risk Due to Diabetes or Pre-Diabetes
Study from MDVIP and Cleveland HeartLab Shows the Positivity Rate for Inflammation Marker Decreased by 69 Percent in Diabetics and 73 Percent in Pre-Diabetics Over Five Years
March 27, 2018
·
5 min read
Previous
7 of 7